VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
RMTI
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
RMTIRockwell Medical, Inc.
$5.60$22M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksRMTIQuarterly Financials

Rockwell Medical, Inc. (RMTI) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Rockwell Medical, Inc. (RMTI) quarterly income statement — complete revenue, gross profit & net income history

RMTI Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue17.34M18.35M15.93M16.07M18.91M24.66M28.32M25.83M22.68M22.09M23.77M18.08M19.67M19.31M18.69M18.68M16.12M15.33M15.99M15.14M
Revenue Growth %-8.34%-25.62%-43.75%-37.79%-16.59%11.64%19.12%42.88%15.29%14.39%27.18%-3.22%21.98%25.97%16.91%23.42%4.21%1.11%4.63%-4.77%
Cost of Goods Sold14.44M14.47M13.65M13.57M15.87M21.03M22.08M21.28M19.61M19.22M21.57M17.05M17.07M16.97M17.91M16.94M16.91M17.56M16.32M15.4M
COGS % of Revenue83.29%78.86%85.73%84.43%83.92%85.28%77.97%82.39%86.49%87.01%90.74%94.29%86.79%87.88%95.84%90.66%104.87%114.55%102.06%101.73%
Gross Profit2.9M3.88M2.27M2.5M3.04M3.63M6.24M4.55M3.06M2.87M2.2M1.03M2.6M2.34M777K1.75M-786K-2.23M-329K-262K
Gross Margin %16.71%21.14%14.27%15.57%16.08%14.72%22.03%17.61%13.51%12.99%9.26%5.71%13.21%12.12%4.16%9.34%-4.87%-14.55%-2.06%-1.73%
Gross Profit Growth %-4.77%6.8%-63.58%-44.99%-0.72%26.52%183.33%340.46%17.89%22.65%183.4%-40.8%430.66%204.89%336.17%766.03%-296.01%-679.48%-195.09%-129.74%
Operating Expenses4.38M4.28M3.86M3.85M4.4M4.15M4.3M4.04M4.39M3.42M3.94M3.99M4.03M4.31M4.49M6.23M5.84M6.13M6.64M7.56M
OpEx % of Revenue25.25%23.31%24.21%23.97%23.27%16.83%15.2%15.62%19.35%15.47%16.57%22.08%20.47%22.3%24%33.33%36.22%39.97%41.55%49.95%
Selling, General & Admin4.38M4.28M3.86M3.85M4.4M4.15M4.3M4.04M4.37M3.25M3.44M3.83M3.75M4.15M4.02M5.3M4.27M4.74M5.42M5.14M
SG&A % of Revenue25.25%23.31%24.21%23.97%23.27%16.82%15.2%15.62%19.27%14.71%14.49%21.16%19.06%21.49%21.49%28.37%26.5%30.9%33.91%33.99%
Research & Development000001K0018K168K494K167K278K156K469K926K1.57M1.39M1.22M2.42M
R&D % of Revenue-----0%--0.08%0.76%2.08%0.92%1.41%0.81%2.51%4.96%9.72%9.07%7.64%15.96%
Other Operating Expenses00000000000000000000
Operating Income-1.48M-398K-1.58M-1.35M-1.36M-519K1.94M515K-1.32M-547K-1.74M-2.96M-1.43M-1.97M-3.71M-4.48M-6.63M-8.36M-6.97M-7.82M
Operating Margin %-8.54%-2.17%-9.95%-8.39%-7.19%-2.1%6.84%1.99%-5.84%-2.48%-7.31%-16.37%-7.26%-10.18%-19.84%-23.99%-41.09%-54.52%-43.61%-51.68%
Operating Income Growth %-8.82%23.31%-181.82%-361.94%-2.72%5.12%211.46%117.4%7.22%72.18%53.16%33.98%78.46%76.48%46.82%42.71%7.74%-3.56%-4.22%-39.62%
EBITDA-969K148K-1.52M-786K-821K24K2.48M1.06M-779K3K-1.17M-2.79M-1.27M-1.32M-3.56M-4.34M-6.49M-7.69M-6.37M-7.2M
EBITDA Margin %-5.59%0.81%-9.56%-4.89%-4.34%0.1%8.75%4.12%-3.44%0.01%-4.93%-15.43%-6.44%-6.82%-19.07%-23.24%-40.24%-50.16%-39.82%-47.53%
EBITDA Growth %-18.03%516.67%-161.44%-173.87%-5.39%700%311.34%138.15%38.52%100.23%67.1%35.75%80.47%82.88%44.01%39.67%1.22%-2.72%-3.66%-42.56%
D&A (Non-Cash Add-back)511K546K61K563K539K543K543K549K545K550K564K170K160K649K143K141K138K668K605K628K
EBIT-1.32M-268K-1.47M-1.22M-1.24M-467K1.97M575K-1.3M-404K-1.46M-2.91M-1.36M-1.93M-3.71M-4.48M-6.62M-8.35M-6.97M-7.82M
Net Interest Income-245K-242K-230K-207K-211K-260K-272K-223K-407K-1.07M-355K-346K-323K-439K-476K-485K-540K-583K-609K-576K
Interest Income37K44K55K69K66K29K30K9K24K42K56K49K64K00005K07K
Interest Expense282K286K285K276K277K289K302K232K431K1.11M411K395K387K439K476K485K540K588K609K583K
Other Income/Expense-125K-156K-169K-143K-155K-237K-272K-172K-407K-965K-135K-346K-323K-396K-482K-485K-536K-582K-609K-577K
Pretax Income-1.6M-554K-1.75M-1.49M-1.51M-756K1.66M343K-1.73M-1.51M-1.87M-3.31M-1.75M-2.36M-4.19M-4.97M-7.16M-8.94M-7.58M-8.4M
Pretax Margin %-9.26%-3.02%-11.01%-9.28%-8.01%-3.07%5.88%1.33%-7.63%-6.84%-7.88%-18.28%-8.9%-12.23%-22.42%-26.59%-44.42%-58.32%-47.42%-55.49%
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-1.6M-554K-1.75M-1.49M-1.51M-756K1.66M343K-1.73M-1.51M-1.87M-3.31M-1.75M-2.36M-4.19M-4.97M-7.16M-8.94M-7.58M-8.4M
Net Margin %-9.26%-3.02%-11.01%-9.28%-8.01%-3.07%5.88%1.33%-7.63%-6.84%-7.88%-18.28%-8.9%-12.23%-22.42%-26.59%-44.42%-58.32%-47.42%-55.49%
Net Income Growth %-5.94%26.72%-205.35%-534.99%12.48%50%188.89%110.38%1.09%35.99%55.32%33.46%75.57%73.58%44.73%40.87%7.61%-3.21%-3.14%-21.87%
Net Income (Continuing)-1.6M-554K-1.75M-1.49M-1.51M-756K1.66M343K-1.73M-1.51M-1.87M-3.31M-1.75M-2.36M-4.19M-4.97M-7.16M-8.94M-7.58M-8.4M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.41-0.14-0.50-0.44-0.44-0.230.510.09-0.59-0.53-0.68-1.80-1.30-2.40-4.40-6.20-9.00-10.50-8.90-9.90
EPS Growth %7.66%38.7%-197.47%-588.76%24.75%56.44%175.44%104.94%54.62%78%84.55%70.97%85.56%77.14%50.56%37.37%1.1%21.05%21.24%9.17%
EPS (Basic)-0.41-0.14-0.50-0.44-0.44-0.230.530.09-0.59-0.53-0.68-1.80-1.30-2.40-4.40-6.20-9.00-10.50-8.90-9.90
Diluted Shares Outstanding3.94M3.94M3.6M3.43M3.41M3.29M3.24M3.2M2.93M2.87M2.75M1.85M1.84M1.15M1.05M880.52K854.51K853.47K853.47K851.85K
Basic Shares Outstanding3.94M3.94M3.6M3.43M3.41M3.29M3.16M3.05M2.93M2.87M2.75M1.85M1.84M1.15M1.05M880.52K854.42K853.47K853.47K848.49K
Dividend Payout Ratio--------------------